Cystic fibrosis-related diabetes testing in Carpino
Find health labs to test for Cystic fibrosis-related diabetes in Carpino and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Hemoglobin Test by Centro Analisi Cliniche San Paolo
Piazza Europa, 70132 Bari BA, Italia
72.2 km
Verified
A Diabetes Test costs €40.00
See Details
Hemoglobin Test by Farmacia Calò
Via Alessandro Manzoni, 183, 70122 Bari BA, Italia
72.2 km
Hemoglobin Test by GVM - Ospedale Santa Maria
Via Antonio de Ferraris, 22, 70124 Bari BA, Italia
72.2 km
Diabetes Test by Laboratorio di analisi cliniche Cusmai
Via Demetrio Marin, 3, 70125 Bari BA
72.2 km
Unverified
A Diabetes Test costs €35.00
See Details
Diabetes Test by Laboratorio di analisi cliniche Cusmai
Via Demetrio Marin, 3, 70125 Bari BA, Italia
72.2 km
Unverified
A Diabetes Test costs €35.00
See Details
Diabetes Test by Nuova Città Onlus - Centro Medico ed Infermieristico
Via Ortolabruna, 23, 70010 Capurso BA, Italia
77.9 km
Diabetes Test by Igea Piedimonte Srl
SP331, 81016 Piedimonte Matese CE, Italia
83.7 km
Diabetes Test by PoliSan Laboratorio Analisi Cliniche
Via Ponte Nove Luci, 16, 85100 Potenza PZ, Italia
83.3 km
Diabetes Test by Laboratorio Materano di Analisi - Analisi Cliniche Specialistiche e di Routine - Dott. Roberto Cicchetti
Via Nazionale, 158, 75100 Matera MT, Italia
90 km
Hemoglobin Test by Clinica San Michele
Via Montella, 16, 81024 Maddaloni CE, Italia
94.4 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
